Reserve Bank of Australia President Brock: The upward inflation risk under discussion has eased, but it has not disappeared. We need to see more progress in basic inflation.Dotinolole, a new drug used by Weicai to treat gout, was approved for marketing in China. On December 10th, Weicai China announced that its new urate reuptake inhibitor Dotinolole tablets (trade name: Youlesi) had been approved by National Medical Products Administration (NMPA) in China, and its indication was gout with hyperuricemia.Australia's policy interest rate is 4.35%, expected to be 4.35%, and the previous value is 4.35%.
Baiao Intelligent: Cancel the absorption and merger of wholly-owned subsidiaries. Baiao Intelligent announced on December 10 that the company intends to cancel the absorption and merger of wholly-owned subsidiaries Kunshan Baisente Materials and Materials Co., Ltd. and Kunshan Baiao Intelligent Logistics Co., Ltd. in consideration of the actual operation and business development plan of the company. This termination will not lead to changes in the scope of the company's merger, the actual rights and interests held by the company will not change, it will not adversely affect the company's production and operation, and there will be no harm to the interests of the company and shareholders.Minister of Malaysia: ZTE will invest 200 million ringgit in Malaysia.Malaysia exported 1.49 million tons of palm oil in November, down 15%.
Australia's 3-year bond yields fell by 3 basis points after the RBA commented on inflation.Treasury futures closed in early trading, with 2-year Treasury futures (TS) up 0.14%, 5-year Treasury futures (TF) up 0.42%, 10-year Treasury futures (T) up 0.64% and 30-year Treasury futures (TL) up 1.23%."Nature" announced the top ten figures in 2024, and two China scientists were selected. On the 9th, the website of the British magazine "Nature" released the list of the top ten figures promoting scientific development in 2024. Among them, two China scientists were selected. The list was compiled by the editors of Nature magazine to record the important scientific progress, events and some key figures this year. Among them, two China researchers who were selected as the top ten were Xu Huji, a rheumatologist from the PLA Naval Medical University, and Li Chunlai, deputy chief designer of the Chang 'e VI mission and a researcher at the National Astronomical Observatory of the Chinese Academy of Sciences. Dr. Xu Huji bravely tried to treat autoimmune diseases with CAR-T cell therapy, which brought hope for the mass production of CAR-T cell therapy. Li Chunlai was a key figure in determining the landing site of Chang 'e-6 probe on the moon, and was also one of the first scientists to analyze the returned samples.
Strategy guide
Strategy guide